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Background: Endovascular aortic repair (EVAR) has become an additional treatment option for patients with infrarenal aortic
aneurysms and suitable aortic morphology. However, endoleaks are commonly encountered and represent a relevant risk for
secondary treatment failure. In addition, impaired renal function or allergic reactions to intravascular iodine application might
represent exclusion criteria for conventional infrarenal endovascular aortic repair using intraoperative angiography with iodine
contrast media. Real-time contrast-enhanced ultrasound (CEUS) with a low mechanical index (MI) is a promising method
recently introduced for follow up after endovascular infrarenal aortic repair.
Methods: In this study, intraoperative CEUS using SonoVue as ultrasound contrast agent was evaluated in 17 patients for
localization of the proximal infrarenal landing zone, the distal iliac fixation area, and identification of endoleaks in patients
suitable for endovascular aortic repair with an infrarenal aortic neck>10 mm and non-aneurysmal common iliac arteries. For
comparison, 20 patients were treated by conventional EVAR using intraoperative fluoroscopy and iodine contrast media.
Results: Intraoperative application of contrast-enhanced ultrasound (iCEUS) for identification of the infrarenal landing
zone and proximal stent graft release was achieved in 14 out of 17 patients (82.4%), as verified by intraoperative
angiography or postinterventional imaging. Intraoperative CEUS-assisted visualization of the distal fixation area
proximal to the level of the iliac bifurcation was achieved in 89.3% (25 out of 28 iliac arteries examined) in comparison
to intraoperative angiography or postinterventional CEUS, computed tomography (CT), or magnetic resonance (MR)
angiography. Three selected patients having contraindications for iodine-based contrast media were treated by iCEUS-
assisted EVAR without the use of any iodine contrast during fluoroscopy. Time for exposure to intraoperative radiation,
volume of contrast medium used, and the number of intraoperative angiographies and postinterventional CT or MR
angiographies were significantly reduced in the iCEUS-assisted EVAR group in comparison to conventional endovascular
aortic treatment (P < .002 or less for all parameters). Intraoperative application of CEUS detected more endoleaks than
conventional EVAR (8/17 vs 4/20; P  .08) treated by proximal stent graft extension in one symptomatic patient with
a type Ia endoleak.
Conclusions: Intraoperative CEUS-assisted EVAR in patients with infrarenal aortic aneurysms represents a new option for
intraoperative visualization of aortoiliac segments required as proximal or distal fixation zones and identification of endoleaks,
especially in those patients with contraindications for usage of iodine-containing contrast agents, in association with a
reduction of iodine contrast media used and radiation exposure during fluoroscopy. (J Vasc Surg 2010;51:1103-10.)Endovascular aortic repair (EVAR) of infrarenal aortic
aneurysms has now become an accepted treatment option
for patients with suitable aortic configuration, when per-
formed by an experienced endovascular surgeon or inter-
ventionalist.1,2 Although early postoperative follow-up
data showed increased survival rates in patients with infra-
renal aortic aneurysms after endovascular aortic repair, dur-
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lost, showing no difference between EVAR and open aortic
surgery after more than 5 years.3
Progression of arteriosclerotic disease, with changes in
aortic morphology, aneurysm progression, stent graft mi-
gration, and mechanical damage of the stent graft material
might contribute to failure of endovascular treatment with
the need for secondary reintervention or conversion to
open surgery and an increased risk for secondary aneurysm
rupture. Incomplete exclusion of the aneurysm sac after
EVAR with persistent blood flow into the aneurysm is
defined as an endoleak and subclassified according to the
site of incomplete sealing between the stent graft and the
aortic wall, the aortic branch vessel involved, possible leak-
age at the stent graft connection sites, or porosity of the
graft material.4 Early and sensitive detection of endoleaks,
which is indeed highly desirable during the initial interven-
tion when endovascular treatment can be administered
immediately, might therefore improve long-term results of
EVAR. However, magnetic resonance (MR)- and com-
puted tomography (CT)-angiography, frequently used for
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with specific side effects and an increased risk of organ
dysfunction or a relevant exposure to radiation, probably
being involved in neoplastic transformation.5,6
In some patients, impaired renal function or a history of
allergic reactions to intravascular iodine application might
represent exclusion criteria for conventional infrarenal en-
dovascular aortic repair using intraoperative fluoroscopic
angiography with iodine contrast media.7-9 Therefore,
other noninvasive methods for intraoperative visualization
of the proximal infrarenal aortic neck and the common iliac
arteries are required for correct endovascular aneurysm
exclusion with appropriate sealing between the aortoiliac
vessel wall and the stent graft. Although intraoperative
endoluminal vascular ultrasound or carbon dioxide angiog-
raphy is used in some institutions and might represent an
alternative intraoperative diagnostic approach for these pa-
tients,10,11 these methods are not available everywhere and
will not be sufficiently able to detect and subclassify en-
doleaks.
Clinical application of contrast-enhanced ultrasonogra-
phy (CEUS) has recently been improved by the introduction
of advanced contrast imaging software such as the Cadence
contrast pulse sequencing (CPS) technology (Siemens Medi-
cal Systems, Forchheim, Germany) and the availability of
second-generation contrast media such as SonoVue (Bracco,
Milan, Italy), consisting of stabilized sulphur hexafluoride
microbubbles.12-14 CEUS has already been established in the
evaluation of tumor perfusion and vascular diagnosis and has
been shown to be a safe contrast agent for vascular and tissue
imaging.15,16 We have recently described our experience us-
ing CEUS for early follow up of patients after endovascular
aortic repair for infrarenal aortic aneurysms.17-19 According to
our experience, CEUS shows high sensitivity and specificity
for early detection of endoleaks without exposure to radiation
nor to potentially nephrotoxic contrastmedia. In addition, we
have recently described the intraoperative application of
CEUS during EVAR for a patient with an infrarenal aortic
aneurysm and preexisting progressive renal dysfunction for
visualization of the proximal and distal aortoiliac sealing zones
to prevent the application of iodine-based contrast medium
during the endovascular intervention.20
In the present study, we have, therefore, further inves-
tigated the value of intraoperative contrast-enhanced ultra-
sonography (iCEUS) during endovascular aortic repair in
selected patients with infrarenal aortic aneurysms suitable
for EVAR for visualisation of proximal and distal aortoiliac
landing zones and early detection of endoleaks. The results
were compared with patients with infrarenal aortic aneu-
rysms treated by conventional EVAR using application of
iodine contrast for intraoperative angiography.
METHODS
Patients. Thirty-seven patients suitable for endovas-
cular aortic repair (EVAR) for abdominal aortic aneurysms
were included in the study between July 2007 and June
2008. Criteria for inclusion into the study were: infrarenal
aortic neck 10 mm, absence of juxtarenal aortic throm-bus, aortic angulation of less than 45 degrees, diameter of
common iliac arteries less than 20 mm, and patent trans-
femoral access to aortoiliac vessels. Seventeen patients re-
ceived iCEUS-assisted endovascular aortic repair for local-
ization of the lowest renal artery, the iliac bifurcation on
both sides, and exclusion of endoleakage following in-
tended aneurysm exclusion. Intraoperative angiography
with iodine-containing contrast fluids was also used in
patients to confirm correct imaging by iCEUS or to identify
intended aortoiliac landing zones in difficult anatomies,
according to the judgement of the vascular surgeon or
interventionalist and in the absence of contraindication for
the use of iodine-based contrast agents. According to the
contraindications described for the application of iodine-
based contrast media, selected patients had endovascular
aortic repair completely without application of iodine con-
trast fluid. Twenty consecutive patients fulfilling the inclu-
sion criteria were treated for infrarenal abdominal aneu-
rysms using conventional fluoroscopy and iodine contrast
medium during endovascular aortic repair without the use
of CEUS. Patients were selected for iCEUS-assisted EVAR
according to the availability of intraoperative CEUS per-
formed by an independent radiologist (C.D.A.) or the
presence of contraindications for the use of iodine contrast
for intraoperative angiography. All patients had at least one
preoperative additional imaging procedure (CTA or
MRA), including dynamic MR without contrast medium
for those patients with impaired renal function or suspected
allergy to iodine-based contrast.
Technique of contrast enhanced ultrasonography.
Contrast-enhancedultrasonographywas performedusingCa-
denceCPS technologywith lowMechanical Index (MI: 0.15-
0.19) on a Siemens ACUSON Sequoia 512 sonography unit
(Siemens Medical Systems, Forchheim, Germany), as de-
scribed previously.17 This new imaging technique leads to a
low applied acoustic pressure to produce images based on
nonlinear acoustic interaction between ultrasound waves
and stabilized microbubbles. These microbubbles oscillate
and resonate, giving continuous contrast enhancement on
gray-scale images. In addition, this technology supports an
effective high frequency imaging and a colorized differen-
tiation of micro- and macrovasculature. In order to avoid
the loss of gray scale resolution in the contrast-enhanced
imaging, we used an overlay technique with improved
resolution (mixed mode) of the contrast-enhanced image
and the gray-scale image. The ultrasound scans were per-
formed by one of the authors (D.A.C.), an experienced
radiologist with a special interest for abdominal in vascular
ultrasound and an experience of more than 500 abdominal
contrast enhanced ultrasound examinations per year.
SonoVue is a second-generation contrast agent consist-
ing of stabilized microbubbles of sulfur hexafluoride gas,
which is eliminated through the respiratory system.16 The
recommended dose for a single intravenous injection is 0.8
to 1.6 mL to obtain improved detectability of contrast
enhancement. During the intraoperative application of
contrast enhanced ultrasonography, the total amount of
ultrasound contrast (SonoVue) used was 3.6 to 6.0 mL.
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gated with CEUS before the intervention, and preoperative
CEUS was recommended for all patients selected for the
EVAR  iCEUS group.
Contraindications for the use of Sonovue were defined
for patients with severe heart diseases, including instable
coronary artery disease, myocardial infarction, acute cardiac
failure and class III/IV cardiac failure, severe arrhythmic
disorders, patients with right-to-left shunts, acute endocar-
ditis, prosthetic valves, severe pulmonary hypertension
(pulmonary artery pressure 90 mm Hg), uncontrolled
systemic hypertension, and patients with adult respiratory
distress syndrome.21
Stent-graft placement with additional intraopera-
tive application of CEUS. Endovascular aortic repair was
performed in an interventional operating room using a
mobile angiography unit (Ziehm Vision R, Ziehm Imag-
ing, Nürnberg, Germany), usually under epidural or local
anesthesia. During the endovascular intervention, patients
received systemic anticoagulation (5000 IU heparin). All
patients were treated with an aortobiiliac bifurcated stent
graft (Cook Zenith, Bjaeverskov, Denmark). In the CEUS-
assisted EVAR group, the position of the lowest renal artery
was visualized by CEUS prior to stent graft insertion or on
the day before the intervention. During intraoperative ap-
plication of CEUS, localization of the lowest renal artery
was transferred to the fluoroscopy screen using the radio-
paque markers of a balloon catheter (diameter: 8 mm;
length: 40 mm). After partial deployment of the proximal
part of the aortic stent graft, the correct infrarenal position-
ing and complete deployment and sealing between the
infrarenal aortic neck and the implanted stent graft was
confirmed by iCEUS. Distal iliac landing zones were also
localized by iCEUS, showing the position of the iliac
bifurcation on both sides. Iliac stent graft extensions were
then released within both common iliac arteries for com-
plete distal aneurysm exclusion. Following balloon dilata-
tion of the proximal fixation, the overlapping zones, and
the iliac landing zones, intraoperative CEUS was used to
exclude any remaining perfusion of the aneurysm sac. En-
doleaks identified were then further characterized accord-
ing to the origin of the blood flow identified, the aortic
branch vessels involved, possible leakage at stent graft con-
nection sites, or graft porosity and classified according to
the description of White et al.4 Release of the proximal
stent graft was intended just below (5 mm) the lowest
renal artery to achieve complete aneurysm exclusion and to
prevent proximal type I endoleak.
Biphasic CT or MR angiography. Biphasic en-
hanced CT was performed preoperatively for planning of
endovascular aortic repair or done postinterventionally to
confirm correct stent graft positioning or detect persistent
endoleaks, using a standard protocol with a 16- or 64-slice
CT scanner (Somatom Sensation 16 or 64, Siemens Med-
ical Systems).
In selected patients with known or suspected allergy to
iodine-containing contrast agents or preexisting renal in-
sufficiency, CT or MR scans without contrast agents wereperformed, and CEUS was additionally used for preopera-
tive planning.
Analysis of data. Reported data were prospectively
collected and documented. Comparison of frequencies was
performed by chi-squared analysis using Pearson=s coeffi-
cient or Fisher’s exact test (both two-sided), and data from
non-parametric variables were evaluated using the analysis
of variance test. A P value of less than 0.05 was considered
to indicate a statistically significant difference. Statistical
analysis was performed using SPSS statistical software (ver-
sion 15.0; SPSS, Chicago, Ill).
RESULTS
Thirty-seven patients with an infrarenal aortic aneu-
rysm suitable for endovascular aortic repair (EVAR) were
treated. In 17 patients, iCEUS-assisted EVAR was used for
detection of proximal or distal aortoiliac landing zone and
detection or exclusion of postinterventional endoleakage.
Additional application of intraoperative angiography with
iodine-based contrast agents was applied according to the
judgement of the endovascular surgeon or interventional-
ist. For comparison, 20 patients had endovascular aortic
repair using conventional fluoroscopy and intraoperative
aortic angiography using iodine-containing contrast fluid.
Patient characteristics were similar in both groups re-
garding age, gender, body mass index (BMI), aneurysm
diameter, and length of infrarenal aortic neck (Table I). All
patients were treated with an aortobi-iliac stent graft sys-
tem. Stent graft implantation was technically successful in
all patients, with no mortality in either group.
The principal steps of the described iCEUS-assisted
endovascular aortic repair are shown in Figs 1 to 5. Visual-
ization of the individual aortic morphology using contrast-
enhanced ultrasonography in comparison to three-dimensional
MRI reconstruction is shown in Fig 1. Identification of the
Table I. Patient characteristics: patients treated for
infrarenal aortic aneurysm by EVAR using conventional
intraoperative contrast media and fluoroscopy without or
with iCEUS
Conventional EVAR EVAR  iCEUS
Number of patients 20 17
Age (years; mean 
SD) 70.9  7.8 71.9  7.4
Gender (male/female) 17/3 14/3
Body mass index
(kg/m2; range) 28.4 (25-35) 28.8 (26-35)
Emergency treatment 1 1
Aneurysm diameter
(cm; mean  SD;
range) 5.7  4.8 (5.4-7.5) 6.0  4.9 (5.6-7.2)
Infrarenal aortic neck
(mm; mean  SD) 14.5  1.2 13.9  0.8
Aortobiiliac stent graft 20 17
Monoiliac stent graft 0 0
EVAR, Endovascular aneurysm repair; iCEUS, intraoperative contrast-
enhanced ultrasonography.proximal landing zone just below the lowest renal artery is
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doluminal contrast-sparing balloon catheter (Fig 2) with si-
multaneous visualization of the radiopaque markers of the
balloon catheter on the fluoroscopy screen. Following aor-
tic stent graft implantation, intraoperative CEUS is used for
confirmation of complete aneurysm exclusion at the level of
Fig 1. Intraoperative visualization of an infrarenal aortic aneu-
rysm using contrast enhanced ultrasonography (a) in comparison
to three-dimensional reconstruction of the magnetic resonance
imaging (MRI) data obtained during MR angiography (b). The
red arrow shows the infrarenal aortic kinking and the yellow arrows
demonstrate the distal landing zone at level of the common iliac
arteries.
Fig 2. Visualization of the proximal infrarenal landing zone by
intraoperative contrast-enhanced ultrasound (iCEUS) using an
endoluminal balloon catheter dilatation (yellow arrows), giving a
contrast-sparing zone within the aortic lumen. The length of the
balloon catheter is measured between the white cross markers
(measured length: 4.07 cm; original length of the catheter as
described by the manufacturer: 4.0 cm). The red arrow shows
again the kinking of the aorta. Stent graft release was planned
within the straight infrarenal aortic segment just below the zone of
aortic kinking.the infrarenal proximal landing zone (Fig 3) and the distaliliac fixation segment (Fig 4). In Fig 5, a type III endoleak
is shown at the connection site of the contralateral iliac
extension stent graft, which was successfully treated by
repeated endoluminal balloon dilatation.
Intraoperative application of CEUS during EVAR re-
sulted in correct identification of the infrarenal landing
zones and successful proximal stent graft release (5 mm
below the lowest renal artery) in 14 out of 17 patients
(82.4%), and was confirmed by at least one imaging modal-
ity: intraoperative angiography (n  10), intraoperative
CEUS (n 17), or diagnostic or postoperative CT angiog-
Fig 3. Intraoperative contrast-enhanced ultrasound (iCEUS):
proximal infrarenal landing zone. iCEUS demonstrating complete
proximal sealing of the stent graft. The yellow arrows show the
sealing of the stent graft along the wall of the excluded proximal
aortic segment. Proximal stent graft release is just below the aortic
kinking, as intended. Red arrows show contrast air bubbles within
the aneurysm sac, as expected, because distal aortic stent graft
extension has not yet been performed. This picture would other-
wise be identical to a distal type II or III endoleak.
Fig 4. Intraoperative contrast-enhanced ultrasonography dem-
onstrating the right iliac stent graft (yellow arrows) extension
without a detectable endoleak.raphy in seven patients. Visualization of the distal fixation
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 5 Kopp et al 1107area at the level of the iliac bifurcation by CEUS in com-
parison to intraoperative angiography or postinterventional
CEUS was successful in 25 out of 28 iliac arteries examined
(89.3%; Table II). Three patients with preexisting renal
insufficiency or known allergy to iodine-containing con-
trast agents were completely and successfully treated by
iCEUS-assisted EVAR for localization of stent graft land-
ing zones, for control of patent perfusion of renal and
internal iliac arteries, and exclusion of relevant endoleaks,
without the use of any iodine contrast media during fluo-
roscopy. Intraoperative use of CEUS-assisted EVAR iden-
tified more endoleaks in comparison to conventional
EVAR using intraoperative iodine-based contrast angiog-
raphy (8/17 vs 4/20; P .08) and required proximal stent
graft extension in one symptomatic patient with a type Ia
endoleak, identified by intraoperative CEUS.
Time for endovascular intervention to exclude infrare-
nal aortic aneurysms was similar in both groups (Table II).
However, time for intraoperative exposure to radiation and
the volume of iodine-containing contrast fluid given were
significantly lower in the iCEUS-assisted EVAR group
(radiation time: 7.48 2.2 minutes [range, 4-12 minutes]
and amount of iodine-containing contrast medium: 39.1
22.4 mL [range, 0-80 mL]) in comparison to the conven-
tional EVAR group (10.7  1.5 minutes [range, 8.5-14
minutes]; P  .001 and 97.0  7.8 mL [range, 60-120
mL]; P  .001, respectively). Final intraoperative angiog-
raphy was performed in all patients treated by conventional
EVAR (20/20; 100%), but only in 8 out of 14 (57.1%; P
.002) patients with normal renal function treated by
iCEUS-assisted EVAR. Similarily, CT or MR angiography
usually performed prior to discharge was applied to all
Fig 5. Postinterventional type III endoleak (white arrows) at the
distal connection site of the left iliac extension (red arrows) en-
doleak following EVAR for an infrarenal aortic aneurysm. The type
III endoleak disappeared after balloon dilatation of the left iliac
stent graft connection site.patients after conventional EVAR (20/20; 100%), but usedonly in 7 out of 14 patients after iCEUS-assisted EVAR (50
%; P  .001).
During early postoperative follow-up after 3 to 6
months, no additional endoleaks were detected in the
iCEUS-assisted EVAR group in comparison to CT angiog-
raphy or postinterventional CEUS, while four new en-
doleaks, one proximal type I and three type II endoleaks,
were postoperatively detected in the conventionally-treated
EVAR group by postinterventional CEUS and/or CT or
MR angiography (0/9 vs 4/16; P  .10), initially not
detected by intraoperative conventional angiography.
More than half of the of the type II endoleaks initially
detected in both groups by intraoperative or postinterven-
tional CEUS (8 out of 14; 57.1%) sealed without any
further intervention.
DISCUSSION
In the present study, intraoperative contrast-enhanced
ultrasonography (iCEUS) was evaluated for visualization of
the proximal aortic and distal iliac landing zones and for
exclusion or detection of relevant endoleaks, probably re-
quiring immediate reintervention. According to our expe-
rience, application of intraoperative contrast-enhanced ul-
trasonography might become an additional imaging
modality, especially for patients with impaired renal func-
tion, allergy to iodine-based contrast fluids, or possible risk
for iodine-induced hyperthyroidism.
Intraoperative CEUS-assisted EVAR was used for visu-
alization of the proximal aortic and distal iliac landing zones
and for detection or exclusion of relevant endoleaks, prob-
ably requiring reintervention. Identification of the lowest
renal artery for correct proximal stent graft release with
complete sealing at the site of the proximal infrarenal aortic
neck was achieved in 14 out of 17 patients. In one patient,
primary stent graft extension for a type I endoleak was
required, which was identified during the endovascular
intervention using iCEUS. Following identification of the
lowest renal artery by CEUS localization, stent graft de-
ployment within the intended distance of 5 mm below
the lowest renal artery was achieved in all patients (14 out
14; 100%) using intraoperative CEUS. In three patients
with a kinked aortic segment and difficult visualization of
the renal arteries, conventional angiography was necessary
to identify the proximal attachment site. Visualization of
the iliac bifurcation was achieved in more than 80% of the
iliac arteries investigated. Although relevant aneurysms of
the common iliac arteries were excluded in this pilot study,
three patients had at least one highly tortuous and calcified
common iliac artery, with a stenosis at the site of the
internal iliac artery preventing correct identification by
iCEUS. According to our early results, in more demanding
vascular conditions with a short and kinked infrarenal aortic
neck or calcified iliac arteries, a more detailed preinterven-
tional investigation of the aortoiliac vessels using CEUS is
recommended and will improve the intraoperative accuracy
of iCEUS-assisted aortoiliac procedures. Therefore, CEUS-
assisted EVAR seems to be feasible for infrarenal aortic
repair in selected patients with a sufficiently long infrarenal
nced
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sonography. Based on our experience, iCEUS-assisted
EVAR seems to be applicable for all types of conventionally
available stent grafts and might be especially helpful for
those with good visualization by ultrasonography and the
possibility of a partial release mechanism. However, the
applicability of iCEUS to other types of abdominal aortic
stent grafts during EVAR for infrarenal aneurysms needs
further evaluation.
Early detection of endoleaks, especially of type I or III
endoleaks during iCEUS-assisted EVAR, might offer the
possibility of early endovascular reintervention to achieve
complete aneurysm exclusion with prevention of endoleak-
mediated persistent systemic pressure in the aneurysm sac
associated with the risk of aneurysm expansion and second-
ary rupture.22-24 As shown in our study, intraoperative
contrast-enhanced ultrasonography was able to identify all
relevant endoleaks in contrast to intraoperative angiogra-
phy or postinterventional CT angiography. In patients with
evidence for a type I or type III endoleak detected intraop-
eratively by iCEUS, immediate reinterventions using bal-
loon dilatation or stent graft extension were performed.
These patients were then followed by CEUS and CTA or
MRA. Patients with type II endoleaks and exclusion of type
I or type III endoleaks underwent a check up by CEUS at
the time of discharge and during early follow up for 12
months. According to this concept, the amount of iodine
contrast medium used during surgery, the intraoperative
time for exposure to radiation, and the number of CT
angiograms usually recommended prior to discharge and
during initial follow up were significantly reduced. There-
fore, based on our initial experience, intraoperative CEUS
seems to be remarkably sensitive and specific to identify
endoleaks following EVAR in comparison to intraoperative
angiography or postoperative CTA or MRA, with the im-
Table II. Perioperative results following endovascular aor
fluoroscopy with iodine-containing contrast agents (n  2
enhanced ultrasonography (n  17)
Time for intervention (min, mean  SD)
Fluoroscopy time (min, mean  SD)
Volume of contrast medium (mL, mean  SD)
Intervention without iodine contrast
Correct visualization of stent graft fixation zone
Lowest renal artery
Distal common iliac artery
Endoleaks detected
Type I
Type II
Type III
Immediate reintervention
Balloon dilatation
Stent graft extension
Conversion to open surgery
Final intraoperative angiography
Computed tomography-angiography prior discharge
EVAR, Endovascular aneurysm repair; iCEUS, intraoperative contrast-enhamediate opportunity for early endovascular reintervention.In selected patients with contraindications for the use
of iodinated contrast fluids, the application of intraopera-
tive CEUS has some remarkable advantages: it is noninva-
sive, reproducible, highly sensitive, and can be performed as
a bedside procedure even in critically ill patients. Although
intraoperative CEUS requires a special ultrasound system
with special software for adequate contrast-enhanced imag-
ing and an experienced investigator, it seems reasonable to
perform endovascular aortic repair under control of intra-
operative CEUS in selected patients to prevent major acute
renal dysfunction, dialysis, and other iodine-associated side
effects. In all the patients investigated by intraoperative
CEUS in our center, we did not observe any systemic
complications or immediate negative effects on pre-existing
renal insufficiency during the early postinterventional fol-
low up. Within the iCEUS-assisted EVAR group, one
patient with preexisting renal dysfunction developed a pro-
longed inflammatory response syndrome over several weeks
with persistent systemic inflammation, elevated tempera-
ture, increased levels of leukocytes, and inflammatory pro-
teins. This patient’s impaired renal function evolved into
secondary renal insufficiency, although no alteration of
renal perfusion could be detected.
Based on our experience, several conditions might
make the use of iCEUS difficult: intraluminal or intra-
abdominal air, severe obesity, or complex vascular anat-
omy. Therefore, we usually perform and strongly recom-
mend preoperative or preinterventional CEUS before the
scheduled intervention, to become familiar with the pa-
tients’ individual conditions and the feasibility to perform
intraoperative CEUS. According to our experience during
the last 5 years with more than 250 CEUS investigations in
post-EVAR patients, the feasibility of performing CEUS
was 98%. Within our study, the infrarenal aortic segment
could be identified in all patients investigated, although we
pair for infrarenal aortic aneurysms using conventional
with additional application of intraoperative contrast-
entional EVAR EVAR  iCEUS P
22  19.3 134  32.4 n.s.
0.7  1.5 7.4  2.2 .001
7.0  7.8 39.1  22.4 .001
0 3 —
/20 (90 %) 14/17 (82.4 %) n.s.
/20 (85 %) 21/24 (89.3 %) n.s.
/20 (20 %) 8/17 (47.1) .08
0 1
4 6
0 1
/20 (10 %) 2/17 (11.8 %) n.s.
2 1
— 1
0 0
/20 (100%) 7/14 (50.0 %) .001
/20 (100%) 8/14 (57.1 %) .002
ultrasonography; n.s., not significantly different.tic re
0) or
Conv
1
1
9
18
17
4
2
20
20had difficulties identifying the common iliac bifurcation in
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above 30 kg/m2, and one of them was not investigated by
CEUS preoperatively. However, in several other patients
with a BMI above 30 kg/m2, we were able to successfully
perform intraoperative CEUS. Therefore, we would not
define a certain BMI as an exclusion criteria for iCEUS
during EVAR.
Contrast-enhanced ultrasonography is an advanced ul-
trasound technique composed of standard B-mode imag-
ing combined with the visualization of vascular flow and
parenchymal microcirculatuion using ultrasound contrast
medium. In our study, iCEUS was performed by a special-
ized radiologist with profound experience in abdominal
and especially in vascular contrast-enhanced ultrasonogra-
phy. However, in our daily practice, vascular surgeons with
a special interest in advanced vascular sonography also
perform iCEUS, which requires a profound knowledge in
abdominal ultrasonography and further training for 6
months in an experienced center with at least 100 addition-
ally performed CEUS examinations. Therefore, the CEUS
technique can also be performed by vascular surgeons with
special experience and interest in advanced vascular ultra-
sound techniques.
Lifelong surveillance is required in patients with ab-
dominal aortic aneurysms treated with stent grafts to detect
aneurysm progression, stent graft migration, or defects in
the stent graft material and structure.23During follow up of
patients treated with EVAR for infrarenal aortic aneurysms,
the technique most commonly used at present for surveil-
lance for endoleak detection is CTA or MRA in combina-
tion with abdominal X-rays in two dimensions.25,26 Duplex
ultrasound has been investigated as an alternative to CTA
for postoperative surveillance because of its noninvasive
nature, its widespread availability, and its relatively inexpen-
sive technology. However, the data reported so far have
shown controversial results.27-29 Contrast-enhanced ultra-
sonography was shown to overcome most limitations of
conventional ultrasound and shows good correlation with
CTA.17 We have recently described our initial experience
using CEUS during follow up of patients after endovascular
aortic repair for infrarenal aortic aneurysms.19 Several other
recently published reports have confirmed our positive
experience and support the use of CEUS for further follow
up and endoleak detection after infrarenal aortic stent graft
repair.30-32
In conclusion, intraoperative contrast-enhanced ultra-
sound might become an additional imaging modality in
selected patients with an abdominal aortic aneurysm requir-
ing endovascular aortic repair in association with an im-
paired renal function, a known allergy to iodine contrast
agents, or suspected iodine-induced hyperthyroidisms. In
patients with suitable aortic configurations, intraoperative
CEUS enables good visualization of proximal and distal
aortoiliac segments for stent graft fixation, leading to a
relevant reduction of the amount of contrast medium used,
the time of exposure to radiation, and the costs for surveil-
lance during early postinterventional follow-up.AUTHOR CONTRIBUTIONS
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